comparemela.com
Home
Live Updates
Form 424B3 NewAmsterdam Pharma Co : comparemela.com
Form 424B3 NewAmsterdam Pharma Co : comparemela.com
Form 424B3 NewAmsterdam Pharma Co
Form 424B3 NewAmsterdam Pharma Co
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Related Keywords
United States ,
California ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Brooklyn ,
New South Wales ,
Australia ,
China ,
Japan ,
Helsinki ,
Eteläuomen Läi ,
Finland ,
Harvard University ,
Massachusetts ,
Morningside ,
Ohio ,
Canada ,
World Health Organization ,
Al Qahirah ,
Egypt ,
New York ,
Gooimeer ,
Netherlands General ,
Switzerland ,
Republic Of China ,
Taiwan General ,
Taiwan ,
Jersey ,
Malta ,
Germany ,
Qure ,
Xizang ,
Mexico ,
Venezuela ,
Liechtenstein ,
Boston ,
Michigan ,
Thailand ,
Peru ,
Libya ,
Florida ,
Italy ,
Norway ,
Miami ,
Chuo Ku ,
Tokyo ,
Delaware ,
Spain ,
Cayman Islands ,
South Korea ,
San Francisco ,
Colombia ,
Utrecht ,
District Of Columbia ,
Ukraine ,
Grand Cayman ,
00 ,
Short Hills ,
Costa Rica ,
Menlo Park ,
State Of New York ,
Macao ,
Macau General ,
Macau ,
India ,
Hong Kong ,
United Kingdom ,
Brazil ,
Stanford ,
Leicestershire ,
Deventer ,
Overijssel ,
Nijenrode ,
Vancouver ,
British Columbia ,
Osaka ,
Oakland ,
Iceland ,
Naarden ,
Monaco ,
Russia ,
Belarus ,
Argentina ,
Singapore ,
Cincinnati ,
Cambridge ,
Cambridgeshire ,
France ,
Denver ,
Colorado ,
America ,
Russian Federation ,
Russian ,
Chinese ,
Dutch ,
Swiss ,
British ,
Kingdom Of The Netherlands ,
Republic Of Korea ,
American ,
Canadian ,
Japanese ,
The Netherlands ,
Thomase Claugus ,
Frances Anne Elizabeth Richard ,
Amryt Pharma ,
Monte Carlo ,
Zhenfu Li ,
Gailina Liew ,
Douglas Kling ,
Nexletol Nexlizet ,
Jamie Topper ,
Sander Slootweg ,
John Kastelein ,
Daniels Lyons ,
Carolg Gallagher ,
Wetboek Van Burgerlijke Rechtsvordering ,
Giles Edward Johnstone Scott ,
Newamsterdam Pharma ,
Carol Gallagher ,
Andrew Acker ,
Louis Lange ,
Michaelf Bigham ,
Jamesn Topper ,
Dezima Pharma ,
Hugo Beekman ,
Novo Nordisk ,
Marc Ditmarsch ,
Gordon Empey ,
John Smither ,
Markn Lampert ,
Nanophoria Bioscience ,
Jason Dinges ,
Dan Estes ,
Christian Berthold Angermayer ,
Johnw Smither ,
Albert Cha ,
Nicholas Downing ,
Hogeschool Markus Verbeek ,
Nigel Crocker ,
James Huang ,
Harold Randall ,
Jefim Gewiet ,
Jill Marie Franklin ,
Kaiser Plaza ,
Peter Kolchinsky ,
Adriel Wenbwo Chan ,
Robertf Baltera ,
Juliette Audet ,
Ivo Bozon ,
Matinas Biopharma ,
Andrew Ian Wignall ,
Clive Meanwell ,
Zonmw Pearl ,
Peter Stuart Allenby Edwards ,
David Topper ,
Michael Davidson ,
Heinz Daxl ,
Van Houten ,
Francois Alain Henri Chesnay ,
Stichting Administratiekantoor Newamsterdam Pharma ,
September Square ,
Richard Michael Lee ,
Gaurav Gupta ,
Genzyme Europe ,
Louise Kooij ,
Innovent Biologics ,
Rajeev Shah ,
Jonathan Jonas ,
Cillian King ,
Stichting Administratiekantoor ,
Chris Cox ,
No Works Council ,
Silicon Valley Bank ,
Outcomes Research Institute ,
Health Insurance Program ,
Partners Os Ltd ,
Union St ,
Northwestern University ,
Trading Fund ,
Harvard College ,
Financial Industry Regulatory Authority ,
Ionis Pharmaceuticals ,
Ra Capital Management ,
Panacea Innovation ,
Presight Is Cornerstone ,
Yale University School Of Medicine ,
Medicare Quality Payment Program ,
United States District Court ,
Forbion Capital Fund Iv Co ,
Transparency Initiative ,
Saga Investments Co ,
Interpretations Committee ,
Entasis Therapeutics Holdings Inc ,
Forbion European Acquisition Corporation Nasdaq ,
Group Information ,
Medpace Holdings Inc ,
Signature Bank ,
Good Laboratory Practice ,
Janus Henderson Investors ,
National Health Commission ,
Dementia Fund Management ,
Frazier Life Sciences Overage Fund ,
Kestra Medical Technologies Ltd ,
Omthera Pharmaceuticals Inc ,
Janus Henderson Horizon Fund ,
Shell Companies Or Former ,
Foreign Exchange ,
Clinical Health ,
Oxitope Pharma Inc ,
Utrecht University ,
European Parliament ,
Clinical Development At Matina Biopharma Holdings Inc ,
Kaiser Foundation Hospitals ,
Articles Of Association Or Dutch ,
Novartis International ,
Japan Pharmaceuticals ,
Securities Exchange ,
Renaissance Aventura ,
Bioplus Acquisition Corp ,
Nasdaq ,
Dementia Fund Co ,
Capital Life Sciences ,
Ascendant Biocapital Fund ,
Forbion Growth Opportunities Fundi Cooperatief ,
Compensation Committee ,
Astellas Pharma Inc ,
Medpace Intermediateco Inc ,
China National Medical Products Administration ,
Tenax Therapeutics Inc ,
Forbion Capital Fund Iv Cooperatief ,
Forbion International Management ,
Xenon Pharmaceuticals Inc ,
Rutgers Business School ,
Altarius Asset Management Ltd ,
Management Services ,
Biotechnology Value Trading Fund ,
Company Working Capital ,
Nyenrode Business University ,
Exchange For Ordinary ,
Group To Menarini ,
Description Of Organization ,
Us Drug Development ,
Frazier Life Sciences ,
Enterprise Chamber Ondernemingskamer ,
Anaptysbio Inc ,
Biotechnology Value Fund ,
Menarini Group ,
Effector Therapeutics Inc ,
European Union ,
University Of Chicago ,
Us Export Administration Regulations ,
Corporate Governance Committee ,
Fovea Pharmaceuticals ,
Public Company Accounting Oversight Board United States ,
Ohio State University School Of Medicine ,
Biden Administration ,
Sea Therapeutics Inc ,
Tour Product Development ,
Nijenrode University ,
Exchange Commission ,
Patient Centered Outcomes Research Institute ,
Principia Biopharma Inc ,
Ua Amgen Technology ,
Molecular Transport Inc ,
International Financial Reporting Standards ,
Amgen Technology ,
Phathom Pharmaceuticals Inc ,
Sienna Biopharmaceuticals Inc ,
European Medicines Agency ,
Mitsubishi Tanabe Pharma Corporation ,
Department Of Financial Services ,
Replimune Group Inc ,
Securities Exchange Commission ,
Newamsterdam Pharma Companynv Ordinary ,
Service Agreement ,
Amygdala Neurosciences Inc ,
Vascular Research Network Inc ,
Office Of Foreign Assets ,
Arrowhead Pharmaceuticals ,
Financial Services ,
Cv Therapeutics Inc ,
Bain Capital Life Sciences Entities ,
Committee For Medicinal Products Human ,
Arcutis Biotherapeutics Inc ,
Aptinyx Inc ,
Gl China Opportunities Carry Gp Ltd ,
Medicines Company Incline ,
Our Limited Operating History ,
University Of Amsterdam ,
Biovex Group Inc ,
Development Expense ,
Us Department ,
Party Service Agreements ,
Recardia Inc ,
Enlaza Therapeutics Inc ,
Portola Inc ,
Abiomed Inc ,
Health Insurance Portability ,
Amsterdam Court ,
Ra Capital Healthcare Fund ,
Frazer Life Sciences Public Fund ,
Coordination Group For Mutual Recognition ,
Mitsubishi Chemical Group Corporation ,
Company Support Agreement ,
Exchange Rate ,
Us Expedited Development ,
Medicxi Ventures Management Jersey ,
Ministry Of Health Labor ,
Capital Corp ,
Bcls Ii Investco ,
Health Care ,
University Of Michigan ,
Frazier Lifesciences Acquisition Corporation ,
Kite Pharmaa Gilead Sciences Inc ,
Us Securities Exchange ,
Holders Of The Company ,
Forum Provision ,
Medpace Acquisition Inc ,
Partner Of Frazier Life Sciences ,
Stealth Biotherapeutics Corp ,
Amgen ,
Forbion Growth Opportunities Fundi Co ,
International Conference On Harmonization ,
Swiss Federal Institute Of Technology ,
Commission Implementing Regulation ,
Exchange On ,
Frazier Life Sciences Public Overage Fund ,
Bay Resource Partners Offshore Master Fund ,
Alpine Immune Sciences Nasdaq ,
Newamsterdam Pharma Holding ,
European Patent Office ,
Audit Committee ,
Morningside Venture Investments ,
Bain Capital Life Sciences Fund ,
Mestag Therapeutics ,
National Lipid Association ,
A Menarini International Licensing ,
Company On ,
Device Agency ,
International Accounting Standards Board ,
Frazier Life Sciences Public Fund ,
Free University Of Amsterdam ,
Biotechnology Fund ,
Intertrust Fund Services Jersey ,
Washington University School Of Medicine ,
Panacea Opportunity Fundi Gp Company Ltd ,
Foreign Exchange Gains Losses ,
American College Of Cardiology ,
Articles Of Association ,
Kaiser Permanente Group ,
Newamsterdam Pharma Company ,
Richard King Mellon Foundation ,
Development Expenses ,
Bvf Gp Holdings ,
Medicines Company ,
Japanese Good Laboratory Practice ,
Dutch Atherosclerosis Society ,
Medicaid Services ,
Seraxis Holdings Inc ,
Forbion Capital Fund Ii Co ,
Cotherix Inc ,
Group Companies ,
Growth Company ,
Centers For Medicare ,
Clinical Development Plan ,
Application Of Passive Foreign Investment Company ,
Medpace Inc ,
Human Services ,
Bain Capital Life Sciences Entities On ,
Articles Of Association Do ,
Newamsterdam Pharma Corporation ,
Us Congress ,
European Union Withdrawal ,
Safety Of Products Including Pharmaceuticals ,
Devices Agency ,
Academic Medical Center ,
Pieris Pharmaceuticals Inc ,
Bain Capital Life Sciences ,
Astrazeneca Pharmaceuticals ,
Us Treasury Department ,
Amunix Pharmaceuticals Inc ,
University Of British Columbia ,
Treasury Department ,
Principal At Novartis Venture Fund ,
Drug Administration ,
Newamsterdam Pharma Investment Corporation ,
Astrazeneca ,
Serum Inc ,
Medicaid Drug Rebate Program ,
Novartis ,
Harvard Business School ,
Regeneron Pharmaceuticals Inc ,
Our Related Party Transactions ,
Administrative Services Agreement ,
Dutch Chamber ,
Vii Co ,
Trust Company ,
Abn Amro ,
Life Sciences Associates ,
Register Of The Netherlands Chamber ,
Company Options ,
Panacea Opportunity Fund ,
Audentes Therapeutics Inc ,
River Renal Companies ,
Mellon Family Investment Company ,
Bain Capital Life Sciences Investors ,
Dutch Tax Authority ,
Department Of Vascular Medicine ,
Directors Service Agreements ,
Frazier Lifesciences Sponsor ,
Nasdaq Stock Market ,
Corvidia Therapeutics Inc ,
Senior Managers Of The Company ,
Drug Administration Law ,
Us Supreme Court ,
Janus Henderson Biotech Innovation Master Fund ,
Dementia Fund Managementbv Philip Scheltens ,
Alantos Pharmaceuticals Inc ,
Net Foreign Exchange Gain Loss ,
Enterprise Chamber ,
Pediatric Research Equity ,
Epiphany Tech Acquisition Corp ,
Services Agreement ,
Amgen Inc ,
Calistoga Pharmaceuticals Inc ,
Regulatory Agency ,
Amgen Technology Onyx ,
Public Health Service ,
Implications Of Being An Emerging Growth Company ,
Onyx Pharmaceuticals Inc ,
University Of Rochester ,
Share Of The Company ,
Department Of Veteran Affairs ,
Clinical Development At Corvidia Therapeutics Inc ,
Party Transactions ,
Health Information Technology For Economic ,
Dutch Central Bank ,
California Department Of Financial Protection ,
Cardurion Pharmaceuticals Inc ,
Deposit Insurance Corporation ,
American Heart Association ,
United States Internal Revenue Service ,
Achaogen Inc ,
Regeneron Pharmaceuticals ,
Duke University ,
Population Health Equity Partners ,
Investment Company ,
Union Square ,
Sterling ,
Bgv Ii Co ,
European Commission ,
Sudo Biosciences Inc ,
Threshold Pharmaceutical Inc ,
Free University ,
Ascendant Biocapital ,
Gilead Sciences ,
Trademark Office ,
Gilead Sciences Inc ,
Your Management Team ,
Financial Conduct Authority ,
Vascular Research Network ,
Department Of Health ,
While Congress ,
Placement Warrants ,
Purchase Ordinary Shares ,
Ordinary Shares ,
Rollover Option Plan ,
Rollover Options ,
Rollover Plan ,
Selling Securityholder ,
Selling Securityholders ,
Investor Rights Agreement ,
Private Placement Warrants ,
Private Placement Warrant ,
Public Warrants ,
Ordinary Share ,
Business Combination ,
Amsterdam Pharma Series ,
Convertible Loan ,
Amsterdam Pharma ,
Securities Act ,
Nasdaq Global Market ,
Prospectus Summary ,
Emerging Growth Company ,
Foreign Private ,
Risk Factors ,
Where You Can Find More ,
Registration Statement ,
Prior Registration Statement ,
Financial Condition ,
Special Note Regarding Forward Looking Statements ,
Closing Date ,
Business Combination Agreement ,
Merger Sub ,
Participating Shareholders ,
Holdco Reorganization ,
Surviving Company ,
Newamsterdam Pharma Options ,
Participating Optionholders ,
Earnout Shares ,
Positive Phase ,
Final Closing Date ,
Foreign Private Issuer ,
Jumpstart Our Business Startups Act ,
Sarbanes Oxley Act ,
Exchange Act ,
Limited Operating History ,
Capital Requirements ,
Product Development ,
Regulatory Approval ,
Shares Eligible ,
Lock Up Agreements ,
Investor Rights ,
General Meeting ,
Dividend Policy ,
Market Price ,
California Department ,
Financial Protection ,
Federal Deposit Insurance Corporation ,
Pediatric Research Equity Act ,
New Drug Application ,
Medical Devices Agency ,
Collaboration With ,
Third Parties ,
Menarini License ,
License Agreement ,
Federal Food ,
Cosmetic Act ,
Chief Executive Officer ,
Chief Scientific Officer ,
Chief Operating Officer ,
Intellectual Property ,
United States Patent ,
Drug Price Competition ,
Patent Term Restoration Act ,
Hatch Waxman Amendments ,
Leahy Smith America Invents Act ,
Trials Regulation ,
Government Regulation ,
President Obama ,
Patient Protection ,
Affordable Care Act ,
Education Affordability Reconciliation Act ,
Public Health Service Act ,
Medicaid Innovation ,
Tax Cuts ,
Jobs Act ,
Tax Act ,
President Biden ,
Executive Order ,
Inflation Reduction Act ,
Budget Control Act ,
Executive Branch ,
American Taxpayer Relief Act ,
Medicare Access ,
Medicare Quality Payment ,
Try Act ,
American Rescue Plan Act ,
Comprehensive Plan ,
Addressing High Drug Prices ,
Anti Kickback Statute ,
Medicaid Remuneration ,
False Claims Act ,
Accountability Act ,
President Trump ,
Most Favored Nation ,
General Data Protection Regulation ,
Federal Trade Commission ,
Attorneys General ,
Telemarketing Sales Rule ,
Telephone Consumer Protection Act ,
Federal Trade Commission Act ,
Corrupt Practices Act ,
Administration Regulations ,
Foreign Assets Controls ,
Financial Position ,
Unaudited Pro Forma Condensed Combined Financial ,
Dutch Corporate Income Tax ,
Dutch Tax Authorities ,
United States Federal Income Tax Considerations ,
Information Statement ,
Resale Registration Statement ,
Resale Shares ,
Hague Convention ,
Court Agreements ,
Foreign Judgments ,
Commercial Matters ,
Dutch Code ,
Civil Procedure ,
Burgerlijke Rechtsvordering ,
Securities Exchange Act ,
Chief Financial Officer ,
Reference Value ,
Warrant Assignment ,
Amendment Agreement ,
Continental Stock Transfer ,
Warrant Assumption Agreement ,
Warrant Assumption ,
Eastern Standard ,
Ordinary Cash Dividend ,
Private Placement ,
Southern District ,
Dutch Corporate Governance ,
Dutch Corporate Governance Code ,
Nasdaq Listing Rule ,
General Meetings ,
Nasdaq Listing Rules ,
Nasdaq Rule ,
Forma Effects ,
Management Team ,
Executive Board ,
Corvidia Therapeutics ,
Chief Medical Officer ,
Omthera Pharmaceuticals ,
Emeritus Professor ,
Vascular Medicine ,
Xenon Pharmaceuticals ,
Certain Relationships ,
Related Person Transactions ,
Cholesterol Treatment Trialists ,
American College ,
Stroke Statistical ,
Lowering Through ,
Prior Attempts ,
Cardiovascular Disease ,
American Medicine ,
Clinical Trials ,
Outcomes Trial ,
Lipid Biomarkers ,
Good Manufacturing Practice ,
Licensed Products ,
Menarini Territory ,
Supply Agreement ,
Patent Cooperation Treaty ,
Hatch Waxman Act ,
Patent Term Extension ,
Risks Related ,
North America ,
Product Approval ,
Approval Process ,
Prescription Drug User Fee Act ,
Complete Response Letter ,
Risk Evaluation ,
Mitigation Strategy ,
Preview Programs ,
Fast Track ,
Fast Track Designated ,
Breakthrough Therapy ,
Written Request ,
Dear Healthcare Provider ,
Attorney General ,
False Claims ,
Health Information Technology ,
Clinical Health Act ,
Physician Payments Sunshine Act ,
Medicaid Average Manufacturer Price ,
Best Price ,
Medicare Average Sales Price ,
Ceiling Price ,
Veteran Affairs ,
Medicare Innovation ,
Security Laws ,
California Consumer Privacy Act ,
California Privacy Rights Act ,
Procedures Governing Approval ,
Medicinal Products ,
European Economic Area ,
Clinical Trials Directive ,
Clinical Trials Regulation ,
Implementing Regulation ,
International Conference ,
Human Use ,
Medicines Agencies ,
Coordination Group ,
Mutual Recognition ,
Decentralised Procedures ,
Common Technical Document ,
Priority Medicines ,
Market Exclusivity ,
Product Characteristics ,
Securing Quality ,
Products Including Pharmaceuticals ,
Medical Devices ,
Medical Devices Act ,
Clinical Practice Guidelines ,
Health Labor ,
Medical Device Agency ,
Drug Regulation ,
Administration Law ,
Drug Registration Regulation ,
Recent Government Reorganization ,
Drug Evaluation ,
Therapy Designation ,
Good Laboratories ,
Foreign Data ,
Technical Guidance Principles ,
Accepting Foreign Drug Clinical Trial Data ,
Drug Good Clinical Practice ,
Trial Process ,
Good Clinical Practices ,
International Council ,
Technical Requirements ,
Drug Inspections ,
Marketing Application ,
Human Capital Resources ,
Commercial Register ,
Netherlands Chamber ,
Contractual Obligations ,
Profit Right Agreement ,
Administrative Expenses ,
Davidson Loan Agreement ,
British Pounds ,
Canadian Dollars ,
Japanese Yen ,
Years Ended December ,
Value Change ,
Convertible Loan Agreement ,
Preferred Shares ,
Subscription Agreement ,
Subscription Price ,
Discounted Subscription Price ,
First Closing ,
Cash Flows ,
Operating Activities ,
Investing Activities ,
Financing Activities ,
Naarden Lease ,
Miami Lease ,
Profit Right ,
Earnout Period ,
Capital Resources ,
Executive Officers ,
Scientific Officer ,
Medical Officer ,
Best Doctors ,
Tenax Therapeutics ,
Silence Therapeutics ,
Ohio State University School ,
Dutch Atherosclerosis ,
North Sea Therapeutics Inc ,
Oxitope Pharma ,
New England Journal ,
Managing Partner ,
Acerta Pharma ,
Amunix Pharmaceuticals ,
Calistoga Pharmaceuticals ,
Entasis Therapeutics Holdings ,
Phathom Pharmaceuticals ,
Threshold Pharmaceutical ,
Alpine Immune Sciences ,
Lassen Therapeutics ,
Seraxis Holdings ,
Enlaza Therapeutics ,
Sudo Biosciences ,
Midas List ,
Forbion Venture Capital ,
Novartis Venture Fund ,
Swiss Federal Institute ,
Washington University School ,
Asset Management ,
Bioplus Acquisition ,
Amygdala Neurosciences ,
Audentes Therapeutics ,
Biological Chemistry ,
Oxyrane Belgium ,
Forbion European Acquisition Corporation ,
Biovex Group ,
Pulmagen Therapeutics ,
Argenta Limited ,
Alantos Pharmaceuticals ,
Impella Cardiosystems ,
Pieris Pharmaceuticals ,
Bain Capital ,
Kestra Medical Technologies ,
Cardurion Pharmaceuticals ,
River Renal ,
Yale University School ,
Sienna Biopharmaceuticals ,
Kite Pharma ,
Applied Molecular Transport ,
Principia Biopharma ,
Chief Commercial Officer ,
Pharma Executive Committee ,
Global Head ,
Portfolio Strategy ,
Pharma Region Europe ,
Officer Qualifications ,
Vice President Clinical ,
Chief Development Officer ,
Gadeta Biotechnology ,
Chief Operating ,
Senior Vice President ,
Clinical Development ,
Matina Biopharma Holdings ,
Rutgers Business ,
Interim Chief Financial Officer ,
Chief Accounting Officer ,
Hogeschool Markus ,
Business Conduct ,
Directors Dividend Policy ,
Executive Officer Award Grants ,
Executive Officer Compensation ,
Dutch Trade Register ,
New York City ,
Anti Dilution Adjustments ,
Market Value ,
Own Securities ,
Indemnification Matters ,
Sanctions Act ,
Dutch Financial Reporting Supervision Act ,
Dutch Authority ,
Financial Markets ,
Stichting Autoriteit Financi ,
Newamsterdam Pharma Option ,
Forbion Capital Fund ,
Morningside Venture Investments Limited ,
Support Agreement ,
Transaction Proposal ,
Lock Up Agreement ,
Davidson Loan ,
Davidson Award Agreement ,
Davidson Depositary Receipts ,
Milestone Closing ,
Discounted Subscription ,
Amsterdam Pharma Shareholders ,
Fully Amended ,
Restated Shareholders ,
Shareholder Agreement ,
Biogeneration Ventures ,
Contract Take Over Agreement ,
Intercompany Agreement ,
Related Persons ,
Sponsor Promissory Note ,
Founder Shares ,
Placement Units ,
Sponsor Support ,
Founder Share ,
Placement Unit ,
Placement Warrant ,
Shareholder Rights ,
Placement Shares ,
Registration Rights Agreement ,
Healthcare Fund ,
Managing Director ,
Wong Yuk Lan ,
Des Citronniers ,
Forbion Growth ,
Growth Management ,
Singapore Manufacturing ,
Amgen Singapore ,
Onyx Pharmaceuticals ,
Administratiekantoor Newamsterdam Pharma ,
Van Osch ,
James Brush ,
Two Union Square ,
Sciences Associates ,
Final Closing ,
Purchase Ordinary ,
Resource Partners Offshore Master Fund ,
Resource Partners ,
Life Sciences Public Fund ,
Life Sciences Public Overage Fund ,
Value Fund ,
Henderson Horizon Fund ,
Ridge Parkway ,
Bay Offshore ,
Bay Resources Partners ,
James Topper ,
Medicxi Ventures Management ,
Medicxi Manager ,
Alain Henri Chesnay ,
Intertrust Fund Services ,
Anne Elizabeth Richard ,
General Partner ,
Panacea Innovation Limited ,
San Mateo ,
Managing Members ,
Farm Road ,
Medpace Acquisition ,
Medpace Intermediateco ,
Medpace Holdings ,
One Kaiser Plaza ,
Ordway Building ,
Swen Lorenz ,
Altarius Asset Management ,
Cornerstone Complex ,
Janus Henderson Biotech ,
Investment Advisers Act ,
Janus Henderson ,
Henderson Biotech ,
Janus Henderson Horizon ,
Henderson Horizon ,
Tanabe Pharma Corporation ,
Chemical Group Corporation ,
Mitsubishi Tanabe Pharma ,
Internal Revenue Code ,
Treasury Regulations ,
Passive Foreign Investment Company Rules ,
Income Tax Consequences ,
Backup Withholding ,
Foreign Financial Assets ,
Specified Foreign Financial Assets ,
Reportable Transaction Disclosure Statement ,
Dutch Tax Considerations ,
Dutch Income Tax Act ,
Dutch Corporate Income Tax Act ,
Dutch Dividend Withholding Tax Act ,
Dutch Resident Entities ,
Dutch Resident Individuals ,
Non Resident Holders ,
Dutch State Secretary ,
Dutch Withholding Tax Act ,
Dutch Regulation ,
Listed Jurisdiction ,
Dutch Resident Entity ,
Dutch Resident Individual ,
Ordinary Share Warrant ,
Subscription Agreements ,
Member State ,
Relevant State ,
Prospectus Regulation ,
Dutch Financial Markets Supervision Act ,
Prospective Investors ,
United Kingdom Prospectus Regulation ,
Markets Act ,
United Kingdom Prospectus ,
Financial Services Act ,
Financial Promotion ,
Shell Companies ,
Former Shell Companies ,
Current Reports ,
Financial Statements ,
Public Company Accounting Oversight Board ,
Ordinary Shares Subject ,
Possible Redemption ,
Liabilities Class ,
Private Placement Units ,
Business Operations ,
Lifesciences Acquisition Corporation ,
Initial Public Offering ,
Initial Public ,
Public Shares ,
Over Allotment Units ,
Private Placement Unit ,
Trust Account ,
Investment Company Act ,
Public Shareholders ,
These Public Shares ,
Financial Accounting Standards Board ,
Accounting Standards Codification ,
Distinguishing Liabilities ,
Restated Memorandum ,
Initial Shareholders ,
Private Placement Shares ,
Combination Period ,
Public Share ,
Going Concern ,
Company Working Capital Loans ,
Working Capital ,
Standards Update ,
Significant Accounting Policies ,
Business Startups Act ,
Cash Equivalents ,
Costs Associated ,
Embedded Derivatives ,
Own Equity ,
Public Offering ,
Income Taxes ,
Earnings Per ,
Accounting Standard Update ,
Convertible Instruments ,
Allotment Units ,
Public Warrant ,
Related Party Transactions ,
Working Capital Loans ,
Administrative Services ,
Ordinary Shares Subject To Possible Redemption ,
Derivative Warrant Liabilities ,
Newly Issued Price ,
Fair Value Measurements ,
Private Warrants ,
Private Warrant ,
Subsequent Events ,
Interim Financial Statements ,
Financial Instruments ,
Hedging Embedded Derivatives ,
Three Months Ended September ,
Nine Months Ended September ,
Fair Value Measurement ,
Equity Securities Subject ,
Contractual Sale Restrictions ,
Warrant Liabilities ,
Value Measurements ,
International Accounting Standards ,
Consolidated Statement ,
Intangible Assets ,
Current Year ,
First Time Adoption ,
Effective January ,
Conceptual Framework ,
Intended Use ,
Onerous Contracts ,
Amendments Issued ,
Not Yet Adopted ,
Making Materiality Judgments ,
Accounting Policies ,
Accounting Estimates ,
Deferred Tax ,
Single Transaction ,
Non Current Liabilities ,
Capital Reorganization ,
Participating Shareholder ,
European Countries ,
Licensed Product ,
Personnel Expense ,
Share Listing Expense ,
Current Prepayments ,
Loans Receivable ,
Matching Rights ,
Financial Risk Management ,
British Pound ,
Value Added Tax ,
Financial Assets ,
Liabilities Fair Value ,
Share Capital ,
Share Premium ,
Share Based Payments ,
Long Term Incentive Plan ,
Vesting Period ,
Good Leaver ,
Depositary Receipts ,
Tranche Options ,
Second Tranche Options ,
Options During ,
Company Option ,
Amsterdam Pharma Options ,
Options Granted ,
Based Payment Expenses Recognized ,
Stock Units ,
Participating Optionholder ,
Depository Receipts ,
Related Parties ,
Senior Managers ,
Management Personnel ,
Chief Science Officer ,
Chief Business Officer ,
Vice President ,
Segment Reporting ,
Chief Operating Decision Maker ,
Supplemental Cash Flow Information ,
Events After ,
Reporting Period ,
Interim Chief Financial ,